Clinical Trial of HY004 Cell Injection in the Treatment of Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

NCT06005649 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor changed product development plan

Conditions

Non-hodgkin Lymphoma

Interventions

BIOLOGICAL: HY004

Sponsor

Juventas Cell Therapy Ltd.